APA (7th ed.) Citation

Bas, O., Sert, L., Balcik, O., Tokatli, M., Boyraz, N., Kavgaci, G., . . . Erman, M. (2024). 1848P Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: Multicentre experience. Annals of Oncology, 35, S1090. https://doi.org/10.1016/j.annonc.2024.08.1943

Chicago Style (17th ed.) Citation

Bas, O., et al. "1848P Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B: Multicentre Experience." Annals of Oncology 35 (2024): S1090. https://doi.org/10.1016/j.annonc.2024.08.1943.

MLA (9th ed.) Citation

Bas, O., et al. "1848P Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B: Multicentre Experience." Annals of Oncology, vol. 35, 2024, p. S1090, https://doi.org/10.1016/j.annonc.2024.08.1943.